Related Experiment Video
Updated: Jun 11, 2026
06:29
Propagation of Dental and Respiratory Cells and Organs in Microgravity
Published on: May 25, 2021
Review article: Current concepts of ameloblastoma pathogenesis
Carolina Cavalieri Gomes1, Alessandra Pires Duarte, Marina Gonçalves Diniz
1Department of Pathology, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Summary
Ameloblastoma, a destructive odontogenic tumor, requires further molecular study for better diagnosis and treatment. Research into its pathogenesis, including cell cycle and signaling molecules, is crucial for developing new prognostic markers and therapies.
Area of Science:
- Oral pathology
- Molecular oncology
- Tumorigenesis
Background:
- Ameloblastoma is a locally destructive and invasive odontogenic tumor.
- Recurrence is common despite surgical removal.
- Molecular pathogenesis remains incompletely understood.
Purpose of the Study:
- To review current molecular findings in ameloblastoma pathogenesis.
- To highlight the need for translational research.
- To explore potential avenues for improved diagnosis and treatment.
Main Methods:
- Literature review of molecular studies on ameloblastoma.
- Discussion of key molecular pathways including clonality, cell cycle, apoptosis, and signaling molecules.
- Analysis of enamel matrix proteins and matrix metalloproteinases.
Main Results:
- Molecular studies reveal insights into ameloblastoma pathogenesis.
- Key areas of investigation include cell cycle regulation, apoptosis, and tumor suppressor genes.
- Enamel matrix proteins and matrix metalloproteinases play significant roles.
Conclusions:
- Translational studies are essential for identifying prognostic markers.
- New diagnostic tools are needed for differentiating unicystic from multicystic ameloblastoma.
- Molecular biology research can lead to more effective treatments for this aggressive tumor.
Related Concept Videos
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...